ACXP: SEC Form 424B3 filed by Acurx Pharmaceuticals Inc.
Stocks in this Quantisnow insightHealth Care
Historical context for ACXP
Across the 16 sessions after earlier ACXP headlines, the stock closed higher 6 times and lower 10 times, with a median move of 4.5% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | ACXP | SPY |
|---|---|---|---|
| May 12, 2026 | Acurx Pharmaceuticals, Inc. Reports First Quarter 2026 results and Provides Business Update | -6.0% | -0.2% |
| May 4, 2026 | Acurx Announces Scientific Poster Presentation of its DNA pol IIIC Inhibitors' Microbiome Evaluation at ESCMID Global 2026 | -1.4% | -0.4% |
| Apr 29, 2026 | Acurx Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase | -4.4% | -0.0% |
| Apr 20, 2026 | Acurx Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 12, 2026 Conference Call and Provide Business Update | -0.8% | -0.2% |
| Apr 17, 2026 | Acurx Pharmaceuticals, Inc. Announces Closing of up to $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules | -4.4% | +1.2% |
| Apr 16, 2026 | Acurx Pharmaceuticals, Inc. Announces up to $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules | -19.7% | +0.2% |
Quantisnow market dataNASDAQ
ACXP
Acurx Pharmaceuticals Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2021
Get push alerts for ACXP
Full ACXP profile on Quantisnow Follow ACXP and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time